Androgen-induced hypertension in angiotensinogen deficient mice: Role of 20-HETE and EETS

Prostaglandins and Other Lipid Mediators

Volumn 116-117, Issue , 2015, Pages 124-130

  Garcia, Victor ^a   Cheng, Jennifer ^a   Weidenhammer, Adam ^a   Ding, Yan ^a   Wu, Cheng Chia ^a   Zhang, Fan ^a   Gotlinger, Katherine ^a   Falck, John R ^b   Schwartzman, Michal L ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

20 HETE; ACE; Androgen; Angiotensinogen; Hypertension

Indexed keywords

20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; 20-HYDROXYEICOSA-6(Z),15(Z)-DIENOIC ACID; ANDROGEN; ANGIOTENSIN DERIVATIVE; HYDROXYICOSATETRAENOIC ACID;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DEFICIENCY; GENETICS; HYPERTENSION; MALE; METABOLISM; MOUSE; MUTANT MOUSE STRAIN;

ANDROGENS; ANGIOTENSINS; ANIMALS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MALE; MICE; MICE, MUTANT STRAINS;

EID: 84939945467     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2014.12.001     Document Type: Article

References (47)

1. J.D. Imig Epoxides and soluble epoxide hydrolase in cardiovascular physiology Physiol Rev 92 1 2012 101 130
2. J.M. Williams, S. Murphy, M. Burke, and R.J. Roman 20-Hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension J Cardiovasc Pharmacol 56 4 2010 336 344
3. T.H. Le, and T.M. Coffman Targeting genes in the renin-angiotensin system Curr Opin Nephrol Hypertens 17 1 2008 57 63
4. B. Cvetkovic, and C.D. Sigmund Understanding hypertension through genetic manipulation in mice Kidney Int 57 3 2000 863 874
5. D. Ai, Y. Fu, and D. Guo Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo Proc Natl Acad Sci U S A 104 21 2007 9018 9023
6. J.D. Imig, X. Zhao, J.H. Capdevila, C. Morisseau, and B.D. Hammock Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension Hypertension 39 2002 690 694
7. O. Jung, R.P. Brandes, and I.H. Kim Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension Hypertension 45 4 2005 759 765
8. S. Varcabova, Z. Huskova, and H.J. Kramer Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system Clin Exp Pharmacol Physiol 40 4 2013 273 281
9. A.H. Khan, J.R. Falck, V.L. Manthati, W.B. Campbell, and J.D. Imig Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury Front Pharmacol 5 2014 216
10. K.D. Croft, J.C. McGiff, A. Sanchez-Mendoza, and M.A. Carroll Angiotensin II releases 20-HETE from rat renal microvessels Am J Physiol Renal Physiol 279 2000 F544 F551
11. M. Alonso-Galicia, K.G. Maier, A.S. Greene, A.W. Cowley Jr., and R.J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regul Integr Comp Physiol 283 2002 R60 R68
12. E. Joly, R. Seqqat, and B. Flamion Increased renal vascular reactivity to ANG II after unilateral nephrectomy in the rat involves 20-HETE Am J Physiol Regul Integr Comp Physiol 291 4 2006 R977 R986
13. V.C. Chabova, H.J. Kramer, and I. Vaneckova Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats Vascul Pharmacol 47 2-3 2007 145 159
14. M.M. Muthalif, N.A. Karzoun, and L. Gaber Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites Hypertension 36 2000 604 609
15. J.H. Parmentier, M.M. Muthalif, A.T. Nishimoto, and K.U. Malik 20-Hydroxyeicosatetraenoic acid mediates angiotensin II-induced phospholipase d activation in vascular smooth muscle cells Hypertension 37 2001 623 629
16. F.A. Yaghini, C. Zhang, and J.H. Parmentier Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth Hypertension 45 6 2005 1182 1187
17. K.M. Dunn, M. Renic, and A.K. Flasch Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats Am J Physiol Heart Circ Physiol 295 6 2008 H2455 H2465
18. F. Zhang, M.H. Wang, and U.M. Krishna Modulation by 20-HETE of phenylephrine-induced mesenteric artery contraction in spontaneously hypertensive and Wistar-Kyoto rats Hypertension 38 2001 1311 1315
19. H. Singh, J. Cheng, and H. Deng Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension Hypertension 50 2007 123 129
20. K. Nakagawa, J.S. Marji, M.L. Schwartzman, M.R. Waterman, and J.H. Capdevila Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension Am J Physiol Regul Integr Comp Physiol 284 2003 R1055 R1062
21. V.R. Holla, F. Adas, and J.D. Imig Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension Proc Natl Acad Sci U S A 98 2001 5211 5216
22. D.N. Muller, C. Schmidt, and E. Barbosa-Sicard Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation Biochem J 403 1 2007 109 118
23. O. Ito, K. Omata, S. Ito, K.M. Hoagland, and R.J. Roman Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid Am J Physiol Regul Integr Comp Physiol 280 2001 R822 R830
24. K.N. Theken, Y. Deng, and R.N. Schuck Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism Am J Physiol Endocrinol Metab 302 5 2012 E500 E509
25. J. Cheng, V. Garcia, and Y. Ding Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction Arterioscler Thromb Vasc Biol 32 8 2012 1917 1924
26. K. Sodhi, C.C. Wu, and J. Cheng CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent Hypertension 56 2010 871 878
27. K. Inoue, K. Sodhi, and N. Puri Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE Am J Physiol Renal Physiol 2009
28. C.C. Wu, J. Cheng, and F.F. Zhang Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of κB kinase Hypertension 57 4 2011 788 794
29. C.C. Wu, S. Mei, and J. Cheng Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase J Am Soc Nephrol 2013
30. H.S. Kim, J.H. Krege, and K.D. Kluckman Genetic control of blood pressure and the angiotensinogen locus Proc Natl Acad Sci U S A 92 7 1995 2735 2739
31. Y. Ding, C.C. Wu, and V. Garcia 20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension Am J Physiol Renal Physiol 305 2013 10
32. H. Vasudevan, V.G. Yuen, and J.H. McNeill Testosterone-dependent increase in blood pressure is mediated by elevated Cyp4A expression in fructose-fed rats Mol Cell Biochem 359 1-2 2012 409 418
33. K.E. Ellison, J.R. Ingelfinger, M. Pivor, and V.J. Dzau Androgen regulation of rat renal angiotensinogen messenger RNA expression J Clin Invest 83 6 1989 1941 1945
34. Y.F. Chen, A.J. Naftilan, and S. Oparil Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats Hypertension 19 5 1992 456 463
35. R. Lima, L.L. Yanes, D.D. Davis, and J.F. Reckelhoff Roles played by 20-HETE: angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats Am J Physiol Regul Integr Comp Physiol 304 3 2013 R248 R251
36. R.L. Davisson, H.S. Kim, and J.H. Krege Complementation of reduced survival: hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes J Clin Invest 99 6 1997 1258 1264
37. Y. Ding, D.E. Stec, and C.D. Sigmund Genetic evidence that lethality in angiotensinogen-deficient mice is due to loss of systemic but not renal angiotensinogen J Biol Chem 276 10 2001 7431 7436
38. K. Tanimoto, F. Sugiyama, and Y. Goto Angiotensinogen-deficient mice with hypotension J Biol Chem 269 50 1994 31334 31337
39. R.A. Skidgel, and E.G. Erdos The broad substrate specificity of human angiotensin I converting enzyme Clin Exp Hypertens A 9 2-3 1987 243 259
40. A.H. Weston, M. Feletou, and P.M. Vanhoutte Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids Br J Pharmacol 145 6 2005 775 784
41. K.M. Gauthier, S.G. Jagadeesh, J.R. Falck, and W.B. Campbell 14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries Hypertension 42 4 2003 555 561
42. C.C. Wu, and M.L. Schwartzman The role of 20-HETE in androgen-mediated hypertension Prostaglandins Other Lipid Mediat 96 1-4 2011 45 53
43. X. Zhao, D.M. Pollock, D.C. Zeldin, and J.D. Imig Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases Hypertension 42 4 2003 775 780
44. E. Kaergel, D.N. Muller, and H. Honeck P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage Hypertension 40 3 2002 273 279
45. D. Ai, J.Y. Shyy, and Y. Zhu Linking an insect enzyme to hypertension: angiotensin II-epoxide hydrolase interactions Kidney Int 77 2 2010 88 92
46. D.N. Muller, J. Theuer, and E. Shagdarsuren A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury Am J Pathol 164 2004 521 532
47. L.A. Cowart, S. Wei, and M.H. Hsu The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands J Biol Chem 277 2002 35105 35112